Philips Respironics BiliChek Benutzerhandbuch Seite 13

8
Notes
Certain medical conditions and medications are known to disrupt
bilirubin-albumin carrying capacity and binding. These factors may
alter the transcutaneous bilirubin measurement by increasing or
decreasing the bilirubin deposition in the skin especially at high
total serum bilirubin concentrations (>15 mg/dL or 255 µmol/L).
Therefore, additional caution should be used in interpreting
the BiliChek measurement in patients with serious illnesses or
complications such as septicemia, Patent Ductus Arteriosus (PDA),
Intravetricular Hemorrhage (IVH), and Respiratory Distress
Syndrome (RDS). In these patients, a separate serum bilirubin
measurement should be considered if the BiliChek indicates elevated
bilirubin levels.
There is limited data on use of the BiliChek on patients under
intensive phototherapy (>30 µW/cm
sided phototherapy, or after exchange transfusions. Caution should
be used in interpreting BiliChek results under these conditions.
Symbols
The following symbols appear on the BiliChek unit or accessories.
Symbol
Attention, consult
instructions for use
Use With
Do Not Reuse
BiliChek user manual
/nm or 1.5 m Wcm
2
Description
Note: A note places emphasis on
an operating characteristic.
), double-
2
Symbol
Indoor Use
Type BF Applied Part
Enter Key
Description